In conclusion, zerumbone improves insulin sensitivity, decreases lipogenesis, and increases lipid oxidation in the liver of HFD-fed hamsters, implying a potential application in the treatment of nonalcoholic fatty liver disease. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.